Opendata, web and dolomites

ExtruLub

Commercialisation of Advanced Extrusion Technologies Delivering Disruptive Innovation for the Next Generation of Catheter Based Medical Devices.

Total Cost €

0

EC-Contrib. €

0

Partnership

0

Views

0

 ExtruLub project word cloud

Explore the words cloud of the ExtruLub project. It provides you a very rough idea of what is the project "ExtruLub" about.

initial    disruptive    oems    skilled    original    batch    reduce    antimicrobial    device    surface    medtronic    jobs    thrombogenic    resins    genuine    alone    15    extrulub    savings    protective    preferred    share    oem    engineering    supply    chemistry    anti    line    polymer    advancing    gain    medical    lean    grow    demonstrated    measured    cardiology    attaining    hollister    whilst    core    manufacturing    science    independent    profile    170mn    generate    harnessing    30    5bn    replace    business    friction    mn    technologies    innovative    company    sits    globally    containment    realising    generation    boston    ca    customers    ambition    diania    function    51    facilitates    eg    assists    enhancement    equating    3mn    gross    alternatives    showed    full    revenue    manufacturer    combined    564mn    markets    13    customer    economic    first    coloplast    model    materials    margins    sub    urology    perspective    catheter    patient    reducing    site    safety    global    drugs    command    extrusion    international    differentiation    world    42    functional    2020    realise    safeguarding    21    scientific    applicable    surfaces    market    23   

Project "ExtruLub" data sheet

The following table provides information about the project.

Coordinator
DIANIA TECHNOLOGIES LIMITED 

Organization address
address: UNIT 120 NUIG BUSINESS INNOVATION CENTRE UPPER NEWCASTLE
city: GALWAY
postcode: H91 Y682
website: n.a.

contact info
title: n.a.
name: n.a.
surname: n.a.
function: n.a.
email: n.a.
telephone: n.a.
fax: n.a.

 Coordinator Country Ireland [IE]
 Project website http://linkedin.com/company/DiaNia-Technologies
 Total cost 71˙429 €
 EC max contribution 50˙000 € (70%)
 Programme 1. H2020-EU.2.3.1. (Mainstreaming SME support, especially through a dedicated instrument)
2. H2020-EU.2.1.2. (INDUSTRIAL LEADERSHIP - Leadership in enabling and industrial technologies – Nanotechnologies)
 Code Call H2020-SMEINST-1-2015
 Funding Scheme SME-1
 Starting year 2015
 Duration (year-month-day) from 2015-07-01   to  2015-11-30

 Partnership

Take a look of project's partnership.

# participants  country  role  EC contrib. [€] 
1    DIANIA TECHNOLOGIES LIMITED IE (GALWAY) coordinator 50˙000.00

Map

 Project objective

ExtruLub is an innovative, disruptive extrusion technology applicable across a range of medical polymer resins, which has the ability to change the surface of a catheter without affecting core device properties. The technology sits in the component sub-supply global market with an initial value of €564mn applicable across all catheter markets (combined value of $42.5bn globally by 2020). From a functional perspective, ExtruLub has the ability to reduce surface friction, generate protective antimicrobial & anti-thrombogenic surfaces & deliver site specific drugs all whilst reducing catheter profile. This enhancement of catheter function assists in safeguarding patient safety & will command genuine product differentiation for the original equipment manufacturer (OEM) of the end device, enabling them to gain market share.From an economic perspective it facilitates a change from lean to batch manufacturing realising cost containment for the target customer.Taking the cardiology sector as an example, an independent study demonstrated ExtruLub would reduce costs for the OEM (eg Boston Scientific, Medtronic etc.) by 51% realising savings of ca. €3mn p.a in one product. In the urology sector, the measured impact showed increased gross margins of ca.13% on one product line alone enabling €21.5 mn p.a. savings for potential customers like Hollister, Coloplast etc. DiaNia Technologies ambition is to grow into a world leading, international technology company, realising market share through disruptive technologies.Our initial goal is to replace current ExtruLub alternatives attaining a 30% market share with the friction product, equating to €170mn in full production.Harnessing advanced polymer chemistry through materials science and engineering has the potential to realise €23.3mn in revenue & 15 new, highly skilled jobs within the first 4 years through a business model preferred by OEMs.This disruptive technology is the key to advancing the next generation of medical devices.

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "EXTRULUB" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an  email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "EXTRULUB" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.2.3.1.;H2020-EU.2.1.2.)

INFINITE (2015)

INnovative laser machine For INdustrial engravIng and 3d TExturing

Read More  

FREE-D (2015)

CNC dynamic mold for producing freely curved glass panels

Read More  

S3D (2015)

Feasibility study to determine the use of ITS technology to replace nuclear density meters in mining, dredging and other areas of hydraulic transport.

Read More